{"id":679,"date":"2025-04-28T09:43:00","date_gmt":"2025-04-28T00:43:00","guid":{"rendered":"https:\/\/www.kchnet.or.jp\/krm\/?page_id=679"},"modified":"2025-11-27T12:49:42","modified_gmt":"2025-11-27T03:49:42","slug":"lung-cancer-group","status":"publish","type":"page","link":"https:\/\/www.kchnet.or.jp\/krm\/staff\/lung-cancer-group\/","title":{"rendered":"\u80ba\u764c\u30b0\u30eb\u30fc\u30d7"},"content":{"rendered":"\n

\u80ba\u764c\u30b0\u30eb\u30fc\u30d7\u306f\u3001\u6a2a\u5c71\u3001\u798f\u7530\u3092\u4e2d\u5fc3\u306b\u3001\u80f8\u90e8\u60aa\u6027\u75be\u60a3\u306e\u8a3a\u7642\u3068\u81e8\u5e8a\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u5c02\u653b\u533b\u30fb\u5c02\u9580\u4fee\u7df4\u533b\u3082\u5404\u7a2e\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u306b\u53c2\u52a0\u3057\u3066\u3001\u5f53\u9662\u306e\u75c7\u4f8b\u306e\u691c\u8a0e\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n
\n

\u8c4a\u5bcc\u306a\u75c7\u4f8b\u3068\u7d4c\u9a13<\/h3>\n\n\n\n

\u5f53\u79d1\u306e\u80ba\u764c\u3092\u306f\u3058\u3081\u3068\u3057\u305f\u80f8\u90e8\u60aa\u6027\u816b\u760d\u306e\u75c7\u4f8b\u6570\u306f\u591a\u304f\u3001\u9662\u5185\u304c\u3093\u767b\u9332\u6570\u3067\u306f\u5168\u56fd\u6709\u6570\u306e\u5b9f\u7e3e\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002
\u7dcf\u5408\u75c5\u9662\u306e\u305f\u3081\u901a\u5e38\u5916\u6765\u3060\u3051\u3067\u306a\u304f\u6551\u547d\u6551\u6025\u30bb\u30f3\u30bf\u30fc\u304b\u3089\u306e\u5165\u9662\u3082\u591a\u304f\u3001\u82e5\u5e74\u8005\u304b\u3089\u9ad8\u9f62\u8005\u3001\u5168\u8eab\u72b6\u614b\u306e\u826f\u3044\u65b9\u3084\u60aa\u3044\u65b9\u3001\u5fc3\u75be\u60a3\u30fb\u814e\u75be\u60a3\u306a\u3069\u5408\u4f75\u75c7\u3092\u6301\u3063\u305f\u65b9\u307e\u3067\u3001\u69d8\u3005\u306a\u75c7\u4f8b\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u306b\u5f53\u305f\u308a\u3001\u6a19\u6e96\u6cbb\u7642\u306e\u5b9f\u8df5\u306b\u52aa\u3081\u3066\u3044\u307e\u3059\u3002
\u30b0\u30eb\u30fc\u30d7\u3067\u306e\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3092\u90311\u56de\u884c\u3044\u3001\u6700\u9069\u306a\u6cbb\u7642\u65b9\u91dd\u3092\u691c\u8a0e\u3059\u308b\u307b\u304b\u3001\u81ea\u5206\u306e\u62c5\u5f53\u75c7\u4f8b\u4ee5\u5916\u306e\u7d4c\u904e\u3092\u898b\u308b\u3053\u3068\u3067\u53c2\u52a0\u8005\u306b\u591a\u304f\u306e\u7d4c\u9a13\u3092\u5f97\u3089\u308c\u308b\u3088\u3046\u306b\u3057\u3066\u3044\u307e\u3059\u3002
\u5f53\u9662\u306e\u75c7\u4f8b\u306e\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u3082\u3061\u3001\u5b66\u4f1a\u767a\u8868\u3084\u5404\u7a2e\u81e8\u5e8a\u7814\u7a76\u30fb\u6cbb\u9a13\u306b\u3064\u3044\u3066\u691c\u8a0e\u304c\u53ef\u80fd\u306a\u74b0\u5883\u3092\u6574\u5099\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<\/div>\n\n\n\n

\n

\u4ed6\u79d1\u3068\u306e\u9023\u643a<\/h3>\n\n\n\n

\u547c\u5438\u5668\u5916\u79d1\u3001\u653e\u5c04\u7dda\u6cbb\u7642\u79d1\u3068\u5354\u529b\u3057\u3066\u8a3a\u7642\u306b\u5f53\u305f\u308a\u30013\u79d1\u3067\u306e\u5408\u540c\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3092\u90311\u56de\u884c\u3063\u3066\u3001\u65e9\u671f\u764c\u3067\u76f8\u8ac7\u306e\u5fc5\u8981\u306a\u30b1\u30fc\u30b9\u3084\u3001\u5468\u8853\u671f\u6cbb\u7642\u3001\u96c6\u5b66\u7684\u6cbb\u7642\u306e\u5bfe\u8c61\u306e\u75c7\u4f8b\u306e\u691c\u8a0e\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u547c\u5438\u5668\u5916\u79d1\u3068\u306f\u547c\u5438\u5668\u30bb\u30f3\u30bf\u30fc\u3068\u3057\u3066\u76f8\u8ac7\u3057\u3084\u3059\u3044\u74b0\u5883\u306b\u3042\u308a\u3001\u60aa\u6027\u75be\u60a3\u306e\u6cbb\u7642\u306e\u307f\u306a\u3089\u305a\u547c\u5438\u5668\u9818\u57df\u306e\u5916\u79d1\u7684\u6cbb\u7642\u306e\u9069\u5fdc\u306b\u3064\u3044\u3066\u9069\u5b9c\u78ba\u8a8d\u3057\u3066\u3044\u307e\u3059\u3002
\u7dcf\u5408\u75c5\u9662\u3067\u5404\u79d1\u304c\u305d\u308d\u3063\u3066\u3044\u308b\u305f\u3081\u3001\u6700\u8fd1\u306e\u514d\u75ab\u7642\u6cd5\u306a\u3069\u5168\u8eab\u306b\u53ca\u3076\u6709\u5bb3\u4e8b\u8c61\u306b\u5bfe\u3057\u3066\u3082\u9662\u5185\u3067\u5bfe\u5fdc\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002
\u5f53\u9662\u306f\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u9023\u643a\u75c5\u9662\u306e\u305f\u3081\u3001\u816b\u760d\u5185\u79d1\u3068\u9023\u643a\u3057\u3066\u304c\u3093\u907a\u4f1d\u5b50\u30d1\u30cd\u30eb\u691c\u67fb\u306e\u9069\u5fdc\u306b\u3064\u3044\u3066\u691c\u8a0e\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<\/div>\n\n\n\n

\n

\u591a\u65bd\u8a2d\u5171\u540c\u81e8\u5e8a\u7814\u7a76<\/h3>\n\n\n\n

\u8907\u6570\u306e\u591a\u65bd\u8a2d\u5171\u540c\u8a66\u9a13\u30b0\u30eb\u30fc\u30d7\u306b\u5c5e\u3057\u3066\u304a\u308a\u3001JCOG, WJOG, OLCSG, TORG, SPIRAL, LOGIK, HOPE\u3068\u3044\u3063\u305f\u30b0\u30eb\u30fc\u30d7\u306e\u81e8\u5e8a\u7814\u7a76\u306b\u53c2\u52a0\u3057\u3001\u30ea\u30a2\u30eb\u30ef\u30fc\u30eb\u30c9\u30c7\u30fc\u30bf\u3067\u306e\u89b3\u5bdf\u7814\u7a76\u3084\u3001\u4ecb\u5165\u7814\u7a76\u306b\u643a\u308f\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u6cbb\u7642\u306e\u8cea\u306e\u5411\u4e0a\u306b\u52aa\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<\/div>\n\n\n\n

\n

\u6cbb\u9a13<\/h3>\n\n\n\n

\u307e\u305f\u5f53\u79d1\u306f\u5404\u7a2e\u6cbb\u9a13\u3092\u53d7\u8a17\u3057\u3066\u304a\u308a\u3001\u65b0\u85ac\u306e\u6cbb\u7642\u958b\u767a\u3092\u63a8\u9032\u3057\u3001\u60a3\u8005\u3055\u3093\u306e\u65b0\u898f\u6cbb\u7642\u3078\u306e\u53c2\u52a0\u306e\u6a5f\u4f1a\u3092\u3082\u305f\u3089\u3059\u3068\u3068\u3082\u306b\u3001\u6a19\u6e96\u6cbb\u7642\u306b\u5bfe\u3059\u308b\u62c5\u5f53\u533b\u306e\u6df1\u3044\u7406\u89e3\u3092\u5f97\u3089\u308c\u308b\u3088\u3046\u306b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<\/div>\n\n\n\n

\n

\u547c\u5438\u5668\u5185\u8996\u93e1\u306b\u3088\u308b\u8a3a\u65ad\u30fb\u6cbb\u7642<\/h3>\n\n\n\n

BAL\u3001TBLB\u3001EBUS-GS\u3001EBUS-TBNA\u3001\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3001\u5c40\u6240\u9ebb\u9154\u4e0b\u80f8\u8154\u93e1\u3068\u3044\u3063\u305f\u547c\u5438\u5668\u5185\u8996\u93e1\u306e\u4e3b\u8981\u306a\u691c\u67fb\u624b\u6280\u3092\u99c6\u4f7f\u3057\u3001\u80ba\u764c\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n<\/div>\n\n\n\n

\n

\u5c02\u9580\u533b\u30fb\u8a8d\u5b9a\u533b\u53d6\u5f97<\/h3>\n\n\n\n

\u5f53\u79d1\u306f\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u306e\u547c\u5438\u5668\u5185\u79d1\u9818\u57df\u5c02\u9580\u7814\u4fee\u306e\u57fa\u5e79\/\u9023\u643a\u65bd\u8a2d\u3001\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u306e\u8a8d\u5b9a\u65bd\u8a2d\u3067\u3042\u308a\u3001\u5404\u7a2e\u5c02\u9580\u533b\u30fb\u8a8d\u5b9a\u533b\u306e\u7533\u8acb\u306b\u5fc5\u8981\u306a\u7d4c\u9a13\u3092\u7a4d\u3080\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u307e\u305f\u3001\u5e0c\u671b\u8005\u306f\u4ed6\u79d1\u3068\u306e\u9023\u643a\u3067\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u306e\u5c02\u9580\u533b\u306e\u7533\u8acb\u306b\u5fc5\u8981\u306a\u7d4c\u9a13\u3092\u7a4d\u3080\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002<\/p>\n<\/div>\n\n\n\n

\n

\u80ba\u764c\u30b0\u30eb\u30fc\u30d7\u306b\u8208\u5473\u3092\u6301\u305f\u308c\u305f\u65b9\u3078<\/h3>\n\n\n\n

\u547c\u5438\u5668\u5185\u79d1\u533b\u306b\u3068\u3063\u3066\u80ba\u764c\u306a\u3069\u306e\u80f8\u90e8\u60aa\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306f\u91cd\u8981\u3067\u3042\u308a\u3001\u5f53\u9662\u3067\u306f\u7dcf\u5408\u75c5\u9662\u3067\u306e\u591a\u5f69\u306a\u7d4c\u9a13\u3092\u7a4d\u3080\u3053\u3068\u304c\u3067\u304d\u308b\u3068\u3068\u3082\u306b\u3001\u81e8\u5e8a\u7814\u7a76\u30fb\u6cbb\u9a13\u3067\u306e\u6cbb\u7642\u958b\u767a\u306b\u643a\u308f\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u8208\u5473\u3092\u6301\u305f\u308c\u305f\u65b9\u306f\u662f\u975e\u3054\u9023\u7d61\u4e0b\u3055\u3044\u3002<\/p>\n\n\n\n

\"\"<\/figure>\n<\/div>\n\n\n\n
\n

\u5f53\u79d1\u304c\u53c2\u52a0\u30fb\u8ca2\u732e\u3057\u305f\u8fd1\u5e74\u306e\u81e8\u5e8a\u7814\u7a76\u3084\u6cbb\u9a13<\/h3>\n\n\n\n
    \n
  • JCOG1404\/WJOG8214L
    Clin Cancer Res. 2025;31(12):2317-2326.<\/li>\n\n\n\n
  • JCOG1404\/WJOG8214L\u3000A1
    Lung Cancer. 2025:208:108756.<\/li>\n\n\n\n
  • \u9032\u5c55\u578b\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308bChemo\uff0bICI
    Lung Cancer. 2025:207:108723.<\/li>\n\n\n\n
  • WJOG10317L
    Lung Cancer. 2025:206:108633.<\/li>\n\n\n\n
  • WJOG13520L
    Lung Cancer. 2025;206:108637.<\/li>\n\n\n\n
  • Hanshin Cancer Group IP001
    Med Oncol. 2025;42(8):304.<\/li>\n\n\n\n
  • OSI-FACT
    Clin Lung Cancer. 2025 Jun 10: S1525-7304(25)00129-9.
    Lung Cancer. 2025;204:108589.
    Lung Cancer. 2023;186:107426.<\/li>\n\n\n\n
  • ACHILLES\/TORG1834.
    J Clin Oncol. 2025;43(18):2049-2058.<\/li>\n\n\n\n
  • JCOG2007 (NIPPON)
    Lancet Respir Med. 2024;12(11):877-887.<\/li>\n\n\n\n
  • JCOG2007 (NIPPON)\u3000A1
    J Thorac Oncol. 2025;20(7):912-927.<\/li>\n\n\n\n
  • APOLLO trial (HOPE)
    JAMA Netw. Open. 6 (2023) e230698.
    Lung Cancer. 2025:199:108056.
    Lung Cancer. 2025;199:108079.<\/li>\n\n\n\n
  • APOLLO trial \u9644\u968f\u7814\u7a76 (HOPE)
    J Immunother Cancer. 2024;12(2):e007987.<\/li>\n\n\n\n
  • Rising-VTE\/NEJ037 Study
    Cancer Med. 2025;14(1):e70568.
    Int J Clin Oncol. 2023;28(1):69-78.
    J Hematol Oncol. 2022;15(1):40.<\/li>\n\n\n\n
  • CJLSG1901
    JTO Clin Res Rep. 2024;6(3):100784.<\/li>\n\n\n\n
  • OLCSG-ICD
    Cancers (Basel). 2024;16(23):4089.
    Int J Cancer. 2024;154(9):1607-1615.
    Cancers (Basel). 2022;14(24):6184.
    J Cancer Res Clin Oncol. 2023;149(8):4933-4938.<\/li>\n\n\n\n
  • DREAM study
    Lung Cancer. 2024:196:107958.<\/li>\n\n\n\n
  • OLCSG2401\/ Platinum-Revival
    Cureus. 2025;17(5):e84709.<\/li>\n\n\n\n
  • OLCSG2101\/ GJG
    Respir Investig. 2024;62(5):897-900.<\/li>\n\n\n\n
  • WJOG15121L (REAL-WIND)
    Lung Cancer. 2024;194:107896.<\/li>\n\n\n\n
  • WJOG12219LTR
    JTO Clin Res Rep. 2024;5(4):100658.<\/li>\n\n\n\n
  • TORG1424\/OLCSG1402 (CARNAVAL)
    Jpn J Clin Oncol. 2024;54(7):805-812.<\/li>\n\n\n\n
  • TORG1835 (NEXT-SHIP study)
    Ann Am Thorac Soc. 2024;21(4):635-643.<\/li>\n\n\n\n
  • TORG1936 (AMBITIOUS)
    Oncologist. 2022;27(9):720-e702.
    J Thorac Oncol 2020;15:1935\u20131942.<\/li>\n\n\n\n
  • WJOG15421L (REVEAL)
    JAMA Netw Open. 2023;6(12):e2347700.<\/li>\n\n\n\n
  • LOGIK 1603\/WJOG 9116L (OCEAN Study).
    JTO Clin Res Rep. 2023;4(12):100587.<\/li>\n\n\n\n
  • WJOG12319LTR
    JTO Clin Res Rep. 2023;4(12):100590.<\/li>\n\n\n\n
  • WJOG13620L.
    Cancer Med. 2023;12(23):21097-21110.<\/li>\n\n\n\n
  • PAPILLON
    N Engl J Med. 2023;389(22):2039-2051.<\/li>\n\n\n\n
  • IMPACT study \u9644\u968f
    Mol Oncol. 2024;18(2):305-316.<\/li>\n\n\n\n
  • WJOG14720 L (B-DASH).
    BMC Cancer. 2023;23(1):902.<\/li>\n\n\n\n
  • Afa-Bev\u8a66\u9a13 (CS-Lung)
    Lung Cancer. 2023;184:107349.<\/li>\n\n\n\n
  • CheckMate 227
    Int J Clin Oncol. 2023;28(10):1354-1368.<\/li>\n\n\n\n
  • WJOG10818L (Alt trial)
    Clin Lung Cancer. 2023;24(6):519-527.
    Lung Cancer . 2022;168:38\u201345.<\/li>\n\n\n\n
  • Lorlatinib\u5f8c\u308d\u5411\u304d\u7814\u7a76
    JTO Clin Res Rep. 2023;4(5):100508.<\/li>\n\n\n\n
  • SUSPECT
    Sci Rep. 2023;13(1):3698.
    Eur J Cancer. 2021:150:63-72.<\/li>\n\n\n\n
  • WJOG5108LFS
    Int J Clin Oncol. 2023;28(1):79-88.<\/li>\n\n\n\n
  • J-ALTA study.
    Int J Clin Oncol. 2022;27(12):1828-1838.<\/li>\n\n\n\n
  • SAMURAI study
    Ther Adv Med Oncol. 2022;14:17588359221116603.<\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    \u80ba\u764c\u30b0\u30eb\u30fc\u30d7\u306f\u3001\u6a2a\u5c71\u3001\u798f\u7530\u3092\u4e2d\u5fc3\u306b\u3001\u80f8\u90e8\u60aa\u6027\u75be\u60a3\u306e\u8a3a\u7642\u3068\u81e8\u5e8a\u7814\u7a76\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u5c02\u653b\u533b\u30fb\u5c02\u9580\u4fee\u7df4\u533b\u3082\u5404\u7a2e\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u306b\u53c2\u52a0\u3057\u3066\u3001\u5f53\u9662\u306e\u75c7\u4f8b\u306e\u691c\u8a0e\u3092\u884c\u3044\u307e\u3059\u3002 \u8c4a\u5bcc\u306a\u75c7\u4f8b\u3068\u7d4c\u9a13 \u5f53\u79d1\u306e\u80ba\u764c\u3092\u306f\u3058\u3081\u3068\u3057\u305f\u80f8\u90e8\u60aa\u6027\u816b\u760d\u306e\u75c7\u4f8b […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":12,"menu_order":201,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-679","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/comments?post=679"}],"version-history":[{"count":0,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/679\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/12"}],"wp:attachment":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/media?parent=679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}